Document is current
Any future updates will be listed below
-
Authors
Willemart, Cyril https://orcid.org/0009-0004-8425-7707
Seurinck, Ruth
Stroobants, Tom
Van Coillie, Samya
De Loor, Jorien
Choi, Sze Men
Roelandt, Ria
Rajapurkar, Mohan
Ligthart, Symen
Jorens, Philippe G.
Benoit, Dominique D.
Saeys, Yvan
Meyer, Evelyne
Hoste, Eric https://orcid.org/0000-0001-9301-8055
Vanden Berghe, Tom https://orcid.org/0000-0002-1633-0974
- License Information
-
More Information
Article History
Received: 6 December 2024
Revised: 3 June 2025
Accepted: 8 July 2025
First Online: 19 July 2025
Competing interests
: TVB owns patents related to ferroptosis inhibitors and is founder of FiriX Therapeutics. EM owns a patent related to CHI3L1. All other authors declare that they have no financial or non-financial interests related to this manuscript. Please refer to the accompanying ICM JE disclosure forms for further details.
